0001231919-25-000297.txt : 20251010 0001231919-25-000297.hdr.sgml : 20251010 20251009185812 ACCESSION NUMBER: 0001231919-25-000297 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251010 DATE AS OF CHANGE: 20251009 EFFECTIVENESS DATE: 20251010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AeroRx Therapeutics, Inc. CENTRAL INDEX KEY: 0002090778 ORGANIZATION NAME: EIN: 881699230 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560436 FILM NUMBER: 251386086 BUSINESS ADDRESS: STREET 1: 11099 NORTH TORREY PINES RD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-869-5635 MAIL ADDRESS: STREET 1: 11099 NORTH TORREY PINES RD, SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0002090778 AeroRx Therapeutics, Inc. 11099 NORTH TORREY PINES RD, SUITE 290 LA JOLLA CA CALIFORNIA 92037 858-869-5635 DELAWARE None None Corporation true 2024 Ahmet Tutuncu, M.D., Ph.D. c/o AeroRx Therapeutics, Inc. 11099 North Torrey Pines Rd, Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Sanford Madigan, Ph.D. c/o AeroRx Therapeutics, Inc. 11099 North Torrey Pines Rd, Suite 290 La Jolla CA CALIFORNIA 92037 Director Tighe Reardon c/o AeroRx Therapeutics, Inc. 11099 North Torrey Pines Rd, Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer John Stuart Patton, Ph.D. c/o AeroRx Therapeutics, Inc. 11099 North Torrey Pines Rd, Suite 290 La Jolla CA CALIFORNIA 92037 Director Heather Preston, M.D. c/o AeroRx Therapeutics, Inc. 11099 North Torrey Pines Rd, Suite 290 La Jolla CA CALIFORNIA 92037 Director Jay B. Lichter, Ph.D. c/o AeroRx Therapeutics, Inc. 11099 North Torrey Pines Rd, Suite 290 La Jolla CA CALIFORNIA 92037 Director Other Health Care Decline to Disclose 06b false 2025-09-25 false true false 0 20751992 10376003 10375989 false 17 0 0 0 false AeroRx Therapeutics, Inc. /s/ Ahmet Tutuncu Ahmet Tutuncu, M.D., Ph.D. Chief Executive Officer 2025-10-09